Guest blogger Bryan Mercurio writes the following: Governments often commission and rely on economic analysis to publicly justify FTA negotiations, but it seems to me that such analyses are becoming increasingly meaningless and even deceptive, at most serving only as a 'best case' scenario and often being used

When I saw today's FT story about a number of Indian states banning Coke and Pepsi because a scientific study had shown that they contained as much as 24 times the amount of permitted pesticide residues, and saw that the soft drink makers had argued that they comply

Marc Busch, Karl Landegger Chair in International Business Diplomacy at Georgetown, has joined our group.  Marc has written widely about international political economy, including extremely interesting empirical work on WTO dispute settlement.

Guest blogger Michael Ewing-Chow of National University of Singapore writes as follows:On 1 Aug 2006, President Bush has extended the Burmese Freedom and Democracy Act 2003 for another 3 years. (See http://www.whitehouse.gov/news/releases/2006/08/20060801.html )The Press Release from the White House

No, my previous post wasn't intened as a rhetorical question.  Simply inexperience at using Typepad.  What I meant to post was: Many recent posts, and much media commentary, have tried to identify the implications of the current impasse in negotiations. There is a rough consensus that failure of

It is a pleasure to welcome two more colleagues to the blog.  Andrew Guzman, professor at Boalt Hall School of Law, is an astute commentator on international regulatory issues, public international law, and international trade law.  In addition to his legal credentials, he holds a doctorate in economics.  Junji Nakagawa

I've heard a number of people suggest that the Doha failure would lead to an increase in WTO complaints relating to agricultural subsidies.  The theory is that Members were hoping to address their concerns through negotiations, but now dispute settlement is the only option.  It seems that we

In more peaceful days (just a month ago, in fact), the Hebrew University of Jerusalem hosted a roundtable on the EC-Biotech case. Participants were Rob Howse, Mary Footer, Gareth Davies,Oren Perez, Christiane Conrad and myself. It's a bit odd to publish commentary on a Panel Report